Skip to main content
. 2025 Mar 11;39(5):407–423. doi: 10.1007/s12149-025-02022-x

Table 1.

Comparison of the advantages and disadvantages between FAPI-X PET/CT and [18F]FDG PET/CT

Criteria Radiopharmaceutical
FAPI-X [18F]FDG
Availability Lower Wide
Volume of evidence Lower Higher
Physiological uptake Lower Higher
Pitfalls Healing and fibrotic processes, muscle tissue, endometrium and breast Inflammation and infection
Therapy Allows theranostic Does not allow therapy